Exploring the therapeutic role of Moringa oleifera in neurodegeneration: antioxidant, anti-inflammatory, and neuroprotective mechanisms

Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increa...

Full description

Saved in:
Bibliographic Details
Published inInflammopharmacology Vol. 33; no. 7; pp. 3653 - 3669
Main Author Goel, Falguni
Format Journal Article
LanguageEnglish
Published Switzerland 01.07.2025
Subjects
Online AccessGet full text
ISSN0925-4692
1568-5608
1568-5608
DOI10.1007/s10787-025-01794-y

Cover

Loading…
Abstract Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increasing investigation for natural drugs, Moringa oleifera, a plant highly accepted for its high nutritional and phytochemical constitution, has become an active candidate with multi-oriented neuroprotective activity. This review discusses the therapeutic potential of Moringa oleifera in neurodegeneration, based on its antioxidant, anti-inflammatory, and neuroprotective activities. The plant's bioactive molecules, flavonoids, phenolic acids, and vitamins exhibit potent free radical-scavenging activity and the ability to modulate crucial inflammatory signaling pathways, like NF-κB and MAPK signaling. Additionally, Moringa oleifera is shown to possess the potential for enhancing neurogenesis, facilitating synaptic plasticity, and neuronal apoptosis protection. Preclinical evidence supports its efficacy in decreasing neuropathological alterations and enhancing cognitive function, whereas initial clinical data suggest a benign safety profile. In spite of these promising observations, additional work is required to confirm its action in human subjects and to standardize therapeutic regimens. This review highlights the promise of Moringa oleifera as an adjunct treatment for the prevention and management of neurodegenerative disorders and points to avenues for future investigation and clinical utility.
AbstractList Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increasing investigation for natural drugs, Moringa oleifera, a plant highly accepted for its high nutritional and phytochemical constitution, has become an active candidate with multi-oriented neuroprotective activity. This review discusses the therapeutic potential of Moringa oleifera in neurodegeneration, based on its antioxidant, anti-inflammatory, and neuroprotective activities. The plant's bioactive molecules, flavonoids, phenolic acids, and vitamins exhibit potent free radical-scavenging activity and the ability to modulate crucial inflammatory signaling pathways, like NF-κB and MAPK signaling. Additionally, Moringa oleifera is shown to possess the potential for enhancing neurogenesis, facilitating synaptic plasticity, and neuronal apoptosis protection. Preclinical evidence supports its efficacy in decreasing neuropathological alterations and enhancing cognitive function, whereas initial clinical data suggest a benign safety profile. In spite of these promising observations, additional work is required to confirm its action in human subjects and to standardize therapeutic regimens. This review highlights the promise of Moringa oleifera as an adjunct treatment for the prevention and management of neurodegenerative disorders and points to avenues for future investigation and clinical utility.Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increasing investigation for natural drugs, Moringa oleifera, a plant highly accepted for its high nutritional and phytochemical constitution, has become an active candidate with multi-oriented neuroprotective activity. This review discusses the therapeutic potential of Moringa oleifera in neurodegeneration, based on its antioxidant, anti-inflammatory, and neuroprotective activities. The plant's bioactive molecules, flavonoids, phenolic acids, and vitamins exhibit potent free radical-scavenging activity and the ability to modulate crucial inflammatory signaling pathways, like NF-κB and MAPK signaling. Additionally, Moringa oleifera is shown to possess the potential for enhancing neurogenesis, facilitating synaptic plasticity, and neuronal apoptosis protection. Preclinical evidence supports its efficacy in decreasing neuropathological alterations and enhancing cognitive function, whereas initial clinical data suggest a benign safety profile. In spite of these promising observations, additional work is required to confirm its action in human subjects and to standardize therapeutic regimens. This review highlights the promise of Moringa oleifera as an adjunct treatment for the prevention and management of neurodegenerative disorders and points to avenues for future investigation and clinical utility.
Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss of neurons, based mostly on oxidative stress, long-term neuroinflammation, and compromised neuroplasticity. In the midst of increasing investigation for natural drugs, Moringa oleifera, a plant highly accepted for its high nutritional and phytochemical constitution, has become an active candidate with multi-oriented neuroprotective activity. This review discusses the therapeutic potential of Moringa oleifera in neurodegeneration, based on its antioxidant, anti-inflammatory, and neuroprotective activities. The plant's bioactive molecules, flavonoids, phenolic acids, and vitamins exhibit potent free radical-scavenging activity and the ability to modulate crucial inflammatory signaling pathways, like NF-κB and MAPK signaling. Additionally, Moringa oleifera is shown to possess the potential for enhancing neurogenesis, facilitating synaptic plasticity, and neuronal apoptosis protection. Preclinical evidence supports its efficacy in decreasing neuropathological alterations and enhancing cognitive function, whereas initial clinical data suggest a benign safety profile. In spite of these promising observations, additional work is required to confirm its action in human subjects and to standardize therapeutic regimens. This review highlights the promise of Moringa oleifera as an adjunct treatment for the prevention and management of neurodegenerative disorders and points to avenues for future investigation and clinical utility.
Author Goel, Falguni
Author_xml – sequence: 1
  givenname: Falguni
  orcidid: 0009-0005-1599-812X
  surname: Goel
  fullname: Goel, Falguni
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40448817$$D View this record in MEDLINE/PubMed
BookMark eNo9kc9u3CAQxlGVKtmkeYEeKo49xOlgMODcqij_pES9tGeE8TihsmEDdpR9grx22N20SOjTzPcDjeY7JgchBiTkK4NzBqB-ZAZKqwrqpgKmWlFtPpEVa6SuGgn6gKygLZaQbX1EjnP-CwBSyfaQHAkQQmumVuTt6nU9xuTDI52fcHuTXeMye0dTHJHGgT7sbEtL6YdiUx9owCXFHh8xlMbsY7igNhR99X3Rs11R-TCMdprsHNNm2-r3z9Ypzuhm_4J0Qvdkg89T_kI-D3bMePqhJ-TP9dXvy9vq_tfN3eXP-8rVjZwr4VDXjDtoZcc5dICoe-RaWdk5jRxsh6KcshNhnRpQWN0V0knbDapz_IR83_9bpnheMM9m8tnhONqAccmG10zwWjbQFPTbB7p0E_Zmnfxk08b8W14B6j3gUsw54fAfYWC2CZl9QqZMY3YJmQ1_BxIJh8g
Cites_doi 10.3390/metabo12070608
10.1093/braincomms/fcad356
10.1039/D4FO03549F
10.1007/s11011-020-00556-9
10.1002/biof.1716
10.1080/10408398.2018.1546668
10.1007/s00702-024-02813-y
10.5530/pj.2018.6s.20
10.1007/s11101-023-09894-9
10.3390/pharmaceutics14102210
10.1155/2024/7694516
10.3390/jcm14051703
10.3390/nu15153454
10.3390/ijms17091454
10.1080/1028415X.2018.1500124
10.1007/978-981-15-4909-0_9
10.3389/fnut.2024.1448130
10.1002/ptr.8079
10.1038/s41392-025-02145-7
10.2174/0118715273325667241212041540
10.3390/molecules30040922
10.3390/biomedicines12061169
10.3389/fimmu.2023.1305933
10.1080/13880209.2016.1223146
10.3923/rjp.2023.01.12
10.1038/s41598-025-97232-8
10.3390/antiox14010074
10.1016/j.heliyon.2024.e27807
10.1038/s41580-024-00757-5
10.4103/pr.pr_101_17
10.1201/9781003392941
10.1016/j.jafr.2024.101217
10.1038/s41380-023-02360-0
10.1016/j.jep.2014.06.037
10.1016/j.jep.2024.117904
10.3390/foods13081153
10.2174/0118715303269893231207071440
10.3390/laws13010010
10.1016/j.phytochem.2014.03.028
10.2174/0109298673344501250109210447
10.32604/biocell.2024.058405
10.1002/ptr.5325
10.1007/s00210-025-03976-5
10.1021/acs.jafc.5c00252
10.1080/07391102.2024.2335300
10.1016/j.arres.2024.100113
10.3389/fphar.2022.1035220
10.1002/mnfr.202400525
10.3390/ijms25063264
10.1038/s41598-023-50600-8
10.3389/fphar.2012.00024
10.1108/NFS-03-2020-0087
10.1002/adhm.202304180
10.1007/s11033-021-06535-2
10.1093/nutrit/nuae025
10.1002/fsn3.4706
10.3390/ddc4010004
10.3390/brainsci13091258
10.1007/978-3-031-28780-0_9
10.24853/mujg.5.1.1-13
10.1007/978-3-030-69677-1_9-1
10.1016/j.phyplu.2024.100532
10.12688/f1000research.157194.2
10.3390/foods13070978
10.1016/j.phrs.2024.107300
10.3390/ijms26072916
10.3390/ijms24032098
10.1186/s40643-025-00861-0
10.1002/fsn3.4312
10.1016/j.jep.2023.117153
10.3390/cells14070511
10.1016/j.ejmech.2024.116359
ContentType Journal Article
Copyright 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Copyright_xml – notice: 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s10787-025-01794-y
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1568-5608
EndPage 3669
ExternalDocumentID 40448817
10_1007_s10787_025_01794_y
Genre Journal Article
Review
GroupedDBID ---
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29I
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
36B
4.4
406
408
40D
40E
53G
5GY
5VS
67Z
6NX
8TC
8UJ
95-
95.
95~
96X
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYXX
AAYZH
ABAKF
ABBBX
ABBRH
ABDBE
ABDBF
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABRTQ
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACSNA
ACSTC
ACUHS
ACZOJ
ADHHG
ADHIR
ADHKG
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEVUW
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFHIU
AFLOW
AFOHR
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMFWP
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
ATHPR
AVWKF
AXYYD
AYFIA
AZFZN
B-.
B0M
BA0
BBWZM
BDATZ
BGNMA
BSONS
CAG
CITATION
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EAP
EAS
EBLON
EBS
EIOEI
EJD
EMB
EMK
EMOBN
EN4
ESBYG
EST
ESX
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
H13
HF~
HG5
HG6
HMJXF
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KAT
KDC
KOV
KPH
LLZTM
M4Y
MA-
MK0
N2Q
NB0
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P9S
PF0
PT4
PT5
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
TUS
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WK8
YLTOR
Z45
ZMTXR
ZOVNA
~8M
~A9
~EX
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c256t-4ce8213c096b330b0ee8de387a6bc8e30abe44440254ac7fe4a8bb33c6abf7bc3
ISSN 0925-4692
1568-5608
IngestDate Fri Jul 11 17:11:04 EDT 2025
Wed Sep 03 02:12:55 EDT 2025
Thu Aug 21 00:38:46 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Oxidative stress
Neuroinflammation
Anti-oxidant
Anti-inflammatory
Moringa Oleifera
Language English
License 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c256t-4ce8213c096b330b0ee8de387a6bc8e30abe44440254ac7fe4a8bb33c6abf7bc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0009-0005-1599-812X
PMID 40448817
PQID 3214326505
PQPubID 23479
PageCount 17
ParticipantIDs proquest_miscellaneous_3214326505
pubmed_primary_40448817
crossref_primary_10_1007_s10787_025_01794_y
PublicationCentury 2000
PublicationDate 2025-07-01
PublicationDateYYYYMMDD 2025-07-01
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Inflammopharmacology
PublicationTitleAlternate Inflammopharmacology
PublicationYear 2025
References MA Elizabeth (1794_CR30) 2020; 35
MJ Rao (1794_CR70) 2025; 14
AM Thawabteh (1794_CR88) 2025; 30
N Guo (1794_CR38) 2024; 9
A Trela-Makowej (1794_CR89) 2022; 12
A Houldsworth (1794_CR41) 2024; 6
J Ceramella (1794_CR20) 2024; 13
A Smith (1794_CR81) 2014; 158
L Fornari Laurindo (1794_CR32) 2024; 14
AA Al-Gendy (1794_CR5) 2016; 54
I Grabska-Kobyłecka (1794_CR37) 2023; 15
P Mostashari (1794_CR57) 2024; 13
J Allen (1794_CR7) 2024; 29
JK Paul (1794_CR66) 2024; 31
UK Azlan (1794_CR11) 2023; 13
E Camilleri (1794_CR19) 2024
S Jamil (1794_CR42) 2025; 13
R Baishya (1794_CR12) 2020; 2020
1794_CR75
G Sita (1794_CR80) 2016; 17
D Zhao (1794_CR94) 2020; 60
G Srivastava (1794_CR84) 2024; 4
S Habtemariam (1794_CR39) 2024; 12
I Ara (1794_CR9) 2022; 23
GM El-Sherbiny (1794_CR31) 2024; 14
A Mohajan (1794_CR55) 2023
1794_CR72
1794_CR78
F Gao (1794_CR34) 2025; 15
M Battaglini (1794_CR15) 2024; 13
N Kumar (1794_CR49) 2023; 13
M Akbari (1794_CR3) 2025; 12
IA Bhat (1794_CR16) 2025
AR Khalatbary (1794_CR48) 2020; 23
R Basu (1794_CR14) 2023; 31
P Joshi (1794_CR46) 2025; 56
CV Mashamaite (1794_CR51) 2024; 20
JA Soto (1794_CR83) 2025; 13
MN Javed (1794_CR43) 2020; 2020
H Mahaveerchand (1794_CR50) 2024; 18
M Naoi (1794_CR59) 2025; 26
S Sabat (1794_CR74) 2025; 12
M Mbikay (1794_CR53) 2012; 3
S Adarthaiya (1794_CR2) 2024; 38
M Masoumvand (1794_CR52) 2024; 24
A Memarzia (1794_CR54) 2021; 47
S Hasan (1794_CR40) 2023; 13
N Chaachouay (1794_CR21) 2025; 4
AA Aljabali (1794_CR6) 2025
EY Villegas-Vazquez (1794_CR91) 2025; 13
NI Soliman (1794_CR82) 2021; 64
JI Obeme-Nmom (1794_CR64) 2024
E Sulastri (1794_CR86) 2018
YR Dewi (1794_CR27) 2024; 5
S Jin (1794_CR45) 2023; 165
J Akhtar (1794_CR4) 2024
A Pareek (1794_CR65) 2023; 24
MA Elawad (1794_CR29) 2024; 68
R Rathi (1794_CR71) 2022; 14
DL Dantas (1794_CR24) 2024; 325
M Shahbaz (1794_CR77) 2024; 12
SJ Stohs (1794_CR85) 2015; 29
BO Popescu (1794_CR67) 2024; 131
B Alsuwayt (1794_CR8) 2025; 6
CT Nemade (1794_CR61) 2025; 13
R Bhushan (1794_CR17) 2025
A Azargoonjahromi (1794_CR10) 2025; 83
B Worku (1794_CR93) 2024; 2024
T Premkumar (1794_CR68) 2024; 10
C Niu (1794_CR62) 2024; 11
C Waterman (1794_CR92) 2014; 103
Q Jiang (1794_CR44) 2025; 10
NJ Dar (1794_CR25) 2020; 256
F Goel (1794_CR36) 2025
MP Bimantio (1794_CR18) 2025; 2025
M Ramakrishnan (1794_CR69) 2024; 11
NR Selvaraj (1794_CR76) 2025; 14
E Gkintoni (1794_CR35) 2025; 14
MR Singh (1794_CR79) 2023
M Gachowska (1794_CR33) 2021; 48
V Suryadevara (1794_CR87) 2018
SC da Renata (1794_CR23) 2025
S Darekar (1794_CR26) 2024
A Bangar (1794_CR13) 2024; 319
1794_CR60
P Upadhyay (1794_CR90) 2024; 23
D Kathuria (1794_CR47) 2023
N Chhikara (1794_CR22) 2021; 51
NH Do (1794_CR28) 2022; 294
RA Nixon (1794_CR63) 2024; 25
YM Abd-Elhakim (1794_CR1) 2025
J Morán (1794_CR56) 2024; 13
A Muscolo (1794_CR58) 2024; 25
References_xml – volume: 12
  start-page: 608
  issue: 7
  year: 2022
  ident: 1794_CR89
  publication-title: Metabolites
  doi: 10.3390/metabo12070608
– volume: 6
  start-page: fcad356
  issue: 1
  year: 2024
  ident: 1794_CR41
  publication-title: Brain Commun.
  doi: 10.1093/braincomms/fcad356
– start-page: 49
  volume-title: Fruits as a Functional Food for Health. Functional Foods
  year: 2023
  ident: 1794_CR47
– year: 2024
  ident: 1794_CR64
  publication-title: Food Function
  doi: 10.1039/D4FO03549F
– volume: 35
  start-page: 829
  year: 2020
  ident: 1794_CR30
  publication-title: Metab Brain Dis
  doi: 10.1007/s11011-020-00556-9
– volume: 47
  start-page: 311
  issue: 3
  year: 2021
  ident: 1794_CR54
  publication-title: BioFactors
  doi: 10.1002/biof.1716
– volume: 60
  start-page: 597
  issue: 4
  year: 2020
  ident: 1794_CR94
  publication-title: Critical Rev Food Sci Nutr
  doi: 10.1080/10408398.2018.1546668
– volume: 131
  start-page: 1329
  issue: 11
  year: 2024
  ident: 1794_CR67
  publication-title: J Neural Transmiss
  doi: 10.1007/s00702-024-02813-y
– year: 2018
  ident: 1794_CR86
  publication-title: Pharmacognosy J
  doi: 10.5530/pj.2018.6s.20
– volume: 23
  start-page: 485
  issue: 2
  year: 2024
  ident: 1794_CR90
  publication-title: Phytochemistry Rev
  doi: 10.1007/s11101-023-09894-9
– volume: 14
  start-page: 2210
  issue: 10
  year: 2022
  ident: 1794_CR71
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics14102210
– ident: 1794_CR75
– volume: 2024
  start-page: 7694516
  issue: 1
  year: 2024
  ident: 1794_CR93
  publication-title: Oxidative Med Cellular Longev
  doi: 10.1155/2024/7694516
– volume: 14
  start-page: 1703
  issue: 5
  year: 2025
  ident: 1794_CR35
  publication-title: J Clin Med
  doi: 10.3390/jcm14051703
– volume: 15
  start-page: 3454
  issue: 15
  year: 2023
  ident: 1794_CR37
  publication-title: Nutrients
  doi: 10.3390/nu15153454
– volume: 17
  start-page: 1454
  issue: 9
  year: 2016
  ident: 1794_CR80
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms17091454
– volume: 23
  start-page: 281
  issue: 4
  year: 2020
  ident: 1794_CR48
  publication-title: Nutr Neurosci
  doi: 10.1080/1028415X.2018.1500124
– volume: 2020
  start-page: 151
  year: 2020
  ident: 1794_CR43
  publication-title: Nanophytomed Concept Clin
  doi: 10.1007/978-981-15-4909-0_9
– volume: 11
  start-page: 1448130
  year: 2024
  ident: 1794_CR69
  publication-title: Front Nutr
  doi: 10.3389/fnut.2024.1448130
– volume: 38
  start-page: 755
  issue: 2
  year: 2024
  ident: 1794_CR2
  publication-title: Phytotherapy Res
  doi: 10.1002/ptr.8079
– volume: 10
  start-page: 76
  issue: 1
  year: 2025
  ident: 1794_CR44
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-025-02145-7
– year: 2025
  ident: 1794_CR17
  publication-title: CNS Neurol Disord-Drug Targets
  doi: 10.2174/0118715273325667241212041540
– volume-title: Phytopharmaceuticals and Herbal Drugs: Prospects and Safety Issues in the Delivery of Natural Products
  year: 2023
  ident: 1794_CR79
– volume-title: Moringa oleifera: A comprehensive review on pharmacology, phytochemistry, and clinical applications
  year: 2024
  ident: 1794_CR26
– volume: 30
  start-page: 922
  issue: 4
  year: 2025
  ident: 1794_CR88
  publication-title: Molecules
  doi: 10.3390/molecules30040922
– volume: 294
  year: 2022
  ident: 1794_CR28
  publication-title: Carbohydrate Polymers
– volume: 2020
  start-page: 175
  year: 2020
  ident: 1794_CR12
  publication-title: Herbal Med India Indigenous Knowl Pract Innov Value
– volume: 12
  start-page: 1169
  issue: 6
  year: 2024
  ident: 1794_CR39
  publication-title: Biomedicines
  doi: 10.3390/biomedicines12061169
– volume: 14
  start-page: 1305933
  year: 2024
  ident: 1794_CR32
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2023.1305933
– volume: 54
  start-page: 3257
  issue: 12
  year: 2016
  ident: 1794_CR5
  publication-title: Pharmaceutical Biol
  doi: 10.1080/13880209.2016.1223146
– volume: 18
  start-page: 1
  year: 2024
  ident: 1794_CR50
  publication-title: Phytochem Rev.
  doi: 10.3923/rjp.2023.01.12
– volume: 13
  start-page: 297
  year: 2025
  ident: 1794_CR61
  publication-title: Pharmacog Phytochem Principles Techniq Clin App.
– volume: 15
  start-page: 11807
  issue: 1
  year: 2025
  ident: 1794_CR34
  publication-title: Sci Rep
  doi: 10.1038/s41598-025-97232-8
– volume: 14
  start-page: 74
  issue: 1
  year: 2025
  ident: 1794_CR70
  publication-title: Antioxidants
  doi: 10.3390/antiox14010074
– year: 2024
  ident: 1794_CR19
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2024.e27807
– volume: 25
  start-page: 926
  issue: 11
  year: 2024
  ident: 1794_CR63
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-024-00757-5
– year: 2018
  ident: 1794_CR87
  publication-title: Pharmacognosy Res
  doi: 10.4103/pr.pr_101_17
– volume: 13
  start-page: 634
  issue: 3
  year: 2025
  ident: 1794_CR91
  publication-title: Biomed
– volume: 6
  start-page: 1
  year: 2025
  ident: 1794_CR8
  publication-title: Inflammopharmacology.
– volume-title: Medicinal Plants for the Management of Neurodegenerative Diseases
  year: 2024
  ident: 1794_CR4
  doi: 10.1201/9781003392941
– volume: 20
  start-page: 101217
  year: 2024
  ident: 1794_CR51
  publication-title: J Agricul Food Res.
  doi: 10.1016/j.jafr.2024.101217
– volume: 13
  start-page: 13
  issue: 8
  year: 2023
  ident: 1794_CR49
  publication-title: Nat Products J
– volume: 29
  start-page: 671
  issue: 3
  year: 2024
  ident: 1794_CR7
  publication-title: Mol Psychiatry
  doi: 10.1038/s41380-023-02360-0
– volume: 158
  start-page: 507
  year: 2014
  ident: 1794_CR81
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2014.06.037
– volume: 325
  year: 2024
  ident: 1794_CR24
  publication-title: Journal of Ethnopharmacology
  doi: 10.1016/j.jep.2024.117904
– volume: 13
  start-page: 1153
  issue: 8
  year: 2024
  ident: 1794_CR57
  publication-title: Foods
  doi: 10.3390/foods13081153
– volume: 24
  start-page: 1355
  issue: 12
  year: 2024
  ident: 1794_CR52
  publication-title: EMIDDT
  doi: 10.2174/0118715303269893231207071440
– volume: 13
  start-page: 10
  issue: 1
  year: 2024
  ident: 1794_CR56
  publication-title: Laws
  doi: 10.3390/laws13010010
– volume: 103
  start-page: 114
  year: 2014
  ident: 1794_CR92
  publication-title: Phytochemistry
  doi: 10.1016/j.phytochem.2014.03.028
– year: 2025
  ident: 1794_CR6
  publication-title: Curr Med Chem
  doi: 10.2174/0109298673344501250109210447
– year: 2025
  ident: 1794_CR23
  publication-title: Biocell
  doi: 10.32604/biocell.2024.058405
– volume: 23
  start-page: 1
  year: 2022
  ident: 1794_CR9
  publication-title: Int J Curr Res Physiol Pharmacol.
– volume: 29
  start-page: 796
  issue: 6
  year: 2015
  ident: 1794_CR85
  publication-title: Phytotherap Res
  doi: 10.1002/ptr.5325
– year: 2025
  ident: 1794_CR36
  publication-title: Naunyn-Schmiedeberg's Arch Pharmacol
  doi: 10.1007/s00210-025-03976-5
– year: 2025
  ident: 1794_CR1
  publication-title: J Agricul Food Chem
  doi: 10.1021/acs.jafc.5c00252
– volume: 2025
  start-page: 5
  year: 2025
  ident: 1794_CR18
  publication-title: Commun Math Biol Neurosci.
– volume: 10
  start-page: 1
  year: 2024
  ident: 1794_CR68
  publication-title: J Biomol Struct Dyn.
  doi: 10.1080/07391102.2024.2335300
– volume: 31
  start-page: 100113
  year: 2024
  ident: 1794_CR66
  publication-title: Adv Redox Res
  doi: 10.1016/j.arres.2024.100113
– volume: 56
  start-page: 152
  issue: 1
  year: 2025
  ident: 1794_CR46
  publication-title: Indian J Prevent Soc Med
– volume: 13
  start-page: 1035220
  year: 2023
  ident: 1794_CR11
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2022.1035220
– volume-title: Quality evaluation of novel biscuits supplimented with watermelon (Citrullus lanatus) seeds and Moringa (Moringa oleifera) leaves powder
  year: 2023
  ident: 1794_CR55
– volume: 68
  start-page: 2400525
  issue: 24
  year: 2024
  ident: 1794_CR29
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.202400525
– volume: 25
  start-page: 3264
  issue: 6
  year: 2024
  ident: 1794_CR58
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms25063264
– ident: 1794_CR60
– volume: 14
  start-page: 1
  issue: 1
  year: 2024
  ident: 1794_CR31
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-50600-8
– volume: 3
  start-page: 24
  year: 2012
  ident: 1794_CR53
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2012.00024
– volume: 51
  start-page: 255
  issue: 2
  year: 2021
  ident: 1794_CR22
  publication-title: Nutr Food Sci
  doi: 10.1108/NFS-03-2020-0087
– volume: 13
  start-page: 2304180
  issue: 12
  year: 2024
  ident: 1794_CR15
  publication-title: Adv Healthcare Mater
  doi: 10.1002/adhm.202304180
– volume: 48
  start-page: 5689
  issue: 7
  year: 2021
  ident: 1794_CR33
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-021-06535-2
– volume: 83
  start-page: e257
  issue: 2
  year: 2025
  ident: 1794_CR10
  publication-title: Nutr Rev
  doi: 10.1093/nutrit/nuae025
– volume: 13
  issue: 1
  year: 2025
  ident: 1794_CR42
  publication-title: Food Sci Nutr
  doi: 10.1002/fsn3.4706
– volume: 4
  start-page: 4
  issue: 1
  year: 2025
  ident: 1794_CR21
  publication-title: Drugs Drug Candidates
  doi: 10.3390/ddc4010004
– volume: 13
  start-page: 1258
  issue: 9
  year: 2023
  ident: 1794_CR40
  publication-title: Brain Sci
  doi: 10.3390/brainsci13091258
– volume: 31
  start-page: 253
  year: 2023
  ident: 1794_CR14
  publication-title: Bioprospect Trop Med Plant
  doi: 10.1007/978-3-031-28780-0_9
– volume: 256
  year: 2020
  ident: 1794_CR25
  publication-title: Journal of ethnopharmacology
– volume: 5
  start-page: 1
  issue: 1
  year: 2024
  ident: 1794_CR27
  publication-title: Muhammadiyah J Geriatr
  doi: 10.24853/mujg.5.1.1-13
– ident: 1794_CR72
– ident: 1794_CR78
  doi: 10.1007/978-3-030-69677-1_9-1
– volume: 4
  issue: 2
  year: 2024
  ident: 1794_CR84
  publication-title: Phytomedicine Plus
  doi: 10.1016/j.phyplu.2024.100532
– volume: 13
  start-page: 1390
  year: 2025
  ident: 1794_CR83
  publication-title: F1000Research
  doi: 10.12688/f1000research.157194.2
– volume: 13
  start-page: 978
  issue: 7
  year: 2024
  ident: 1794_CR20
  publication-title: Foods
  doi: 10.3390/foods13070978
– volume: 9
  start-page: 107300
  year: 2024
  ident: 1794_CR38
  publication-title: Pharmacol Res.
  doi: 10.1016/j.phrs.2024.107300
– volume: 26
  start-page: 2916
  issue: 7
  year: 2025
  ident: 1794_CR59
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms26072916
– volume: 64
  start-page: 5585
  issue: 10
  year: 2021
  ident: 1794_CR82
  publication-title: Egypt J Chem
– volume: 12
  start-page: 867
  issue: 4
  year: 2025
  ident: 1794_CR3
  publication-title: Int J New Chem
– volume: 24
  start-page: 2098
  issue: 3
  year: 2023
  ident: 1794_CR65
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24032098
– volume: 165
  year: 2023
  ident: 1794_CR45
  publication-title: Biomed Pharmacother
– volume-title: Apoptosis-mechanisms, regulation in pathology, and therapeutic potential
  year: 2025
  ident: 1794_CR16
– volume: 12
  start-page: 27
  issue: 1
  year: 2025
  ident: 1794_CR74
  publication-title: Bioresourc Bioprocess
  doi: 10.1186/s40643-025-00861-0
– volume: 12
  start-page: 6157
  issue: 9
  year: 2024
  ident: 1794_CR77
  publication-title: Food Sci Nutrition
  doi: 10.1002/fsn3.4312
– volume: 319
  year: 2024
  ident: 1794_CR13
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2023.117153
– volume: 14
  start-page: 511
  issue: 7
  year: 2025
  ident: 1794_CR76
  publication-title: Cells
  doi: 10.3390/cells14070511
– volume: 11
  start-page: 116359
  year: 2024
  ident: 1794_CR62
  publication-title: European J Med Chem
  doi: 10.1016/j.ejmech.2024.116359
SSID ssj0006769
Score 2.373185
SecondaryResourceType review_article
Snippet Neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and other cognitive impairment conditions in elderly are defined by progressive loss...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
StartPage 3653
SubjectTerms Animals
Anti-Inflammatory Agents - isolation & purification
Anti-Inflammatory Agents - pharmacology
Antioxidants - isolation & purification
Antioxidants - pharmacology
Humans
Moringa oleifera - chemistry
Neurodegenerative Diseases - drug therapy
Neurodegenerative Diseases - metabolism
Neuroprotective Agents - isolation & purification
Neuroprotective Agents - pharmacology
Oxidative Stress - drug effects
Plant Extracts - isolation & purification
Plant Extracts - pharmacology
Title Exploring the therapeutic role of Moringa oleifera in neurodegeneration: antioxidant, anti-inflammatory, and neuroprotective mechanisms
URI https://www.ncbi.nlm.nih.gov/pubmed/40448817
https://www.proquest.com/docview/3214326505
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB2MvZetu2Q0NRl8aDdmyZbVvZayUQUcfEuibkezjkrHapUnYsj-wv72jiy9LVliXBxErsazwfTnSkb5zRMj7VBiIpOEsUTrFAgxTQh8yCVml0SXi0jiV7xd5Oks-X6QXo9H3YXTJ0nwofv41ruR_UMU6xNVGyd4B2a5RrMD3iC-WiDCW_4RxL6Cz08dBKFUnGjxzH-sDvLQaFm2XN1wKyxIuXcLpVtuhrerxx7zUPg-BvWTYReTLlduHb1We7uaQ3MGKjq7Ahg7PFyHp-ddWGO_ubK77xNi9arTxwoAT_e1yVc-Hyw5x2klUu_VDrEPf2ptSCNbThnFJrobm1ee5CDTKBrZSSJ8mOIy7QvozW7ZsOm9jnNG2MNcTa0TYuh_B2l37jYGtkxv2qZltGzm2kbs28vU9cj9G_8IefTGLj7sh3Op-XZLG8BtDtFWIudzox58zmlvcFDddmT4iu8HPoMeeNI_JCOo98uAsKCn2yP65h2Y9odOeN4sJ3afnA9CekF8dySgSjA5IRi3JaFPRQDLakozOa7pFsiM6oNiEbhHMVpV0g160p9dTMjv5NP14ysLpHazAafSSJQWoOBIF-shGCG44gCpBqExLUygQXBtI8GXTMegiqyDRyuA3C6lNlZlCPCM7dVPDC0JFhNNOBVGW8TKBlBtQVVRUqY6hlMqIMTloEcivfZKW_HbMx-RdC1KOttRukOkamtUit4d2oTuDTsGYPPfode0lPMGxLspe3ulZr8jD_s_zmuwsb1bwBmexS_PWMe43hkigZw
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+therapeutic+role+of+Moringa+oleifera+in+neurodegeneration%3A+antioxidant%2C+anti-inflammatory%2C+and+neuroprotective+mechanisms&rft.jtitle=Inflammopharmacology&rft.au=Goel%2C+Falguni&rft.date=2025-07-01&rft.issn=0925-4692&rft.eissn=1568-5608&rft.volume=33&rft.issue=7&rft.spage=3653&rft.epage=3669&rft_id=info:doi/10.1007%2Fs10787-025-01794-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10787_025_01794_y
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0925-4692&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0925-4692&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0925-4692&client=summon